Form 483

EMSL Analytical, Inc. DBA MPL Laboratories Form 483, 2026-05-21

FDA issued a Form 483 to EMSL Analytical, Inc. DBA MPL Laboratories on 2026-05-21 with 3 public-safe observations.

483· Form 483 issuedHuman Drugs3 observations

EMSL Analytical, Inc. DBA MPL Laboratories · Sparta, United States · Issued May 21, 2026

Overview

  • 3 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 3 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

21 May 2026
21 CFR 211.165(e)

Test methods

Cited by Anthony J Donato, Jenny Sung, Emmanuel T Donyina

21 May 2026
21 CFR 211.68(a)

Calibration/Inspection/Checking not done

Cited by Anthony J Donato, Jenny Sung, Emmanuel T Donyina

21 May 2026
21 CFR 211.68(b)

Computer control of master formula records

Cited by Anthony J Donato, Jenny Sung, Emmanuel T Donyina

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.165(e)Cited across public-safe Form 483 observations1x
21 CFR 211.68(a)Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 3 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere